Recombinant MAPT anticorps
Aperçu rapide pour Recombinant MAPT anticorps (ABIN7127835)
Antigène
Voir toutes MAPT AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- MAPT Recombinant Monoclonal Antibody
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human Tau
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC:1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Autre désignation
- MAPT
-
Sujet
-
Background: Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
Aliases: Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau), MAPT, MAPTL MTBT1 TAU
-
UniProt
- P10636
-
Pathways
- Signalisation MAPK, Dynamique des Microtubules, M Phase, Regulation of Cell Size
Antigène
-